Pharm Exec Podcast
Pharmaceutical Executive Daily: FDA Lifts Clinical Hold on NUZ-001
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:02:56
- Mas informaciones
Informações:
Sinopsis
In today’s Pharmaceutical Executive Daily, we cover the FDA lifting its clinical hold on Neurizon Therapeutics’ lead program Nuz-001, the agency’s export ban on Sun Pharma’s Halol facility, and new insights on how small biotechs can better navigate regulatory and market complexities.